Developer docs
API playgroundTry for free, no card

Search company profiles

Invivo Analytics

Full company profile

uuid000b5zw

Namestring
Invivo Analytics
Legal namestring
InVivo Analytics, Inc.
Websiteurl
invivo.ax
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Invivo Analytics, Inc. is a private, all-remote SaaS company headquartered in New York that builds AI-powered preclinical imaging analysis software for pharmaceutical, biotech, and academic research buyers. Founded in 2012 by Neal Paragas (Columbia University, biology) and Alexander Klose (Freie University, physics), the company originated from work at Columbia's preclinical imaging facility and is supported by NIH, the National Cancer Institute, and Convergence Design Lab. Its core platform, InVivoAX, is a cloud-native radiomics engine that automates multi-modal image quantification, organ segmentation, and biodistribution analysis to replace manual, operator-dependent workflows in drug discovery and disease modeling. Company-published claims include 100x faster analysis, 3x more data per study, and 5x lower per-subject cost relative to traditional contract research organizations.

The product portfolio combines proprietary hardware with software modules. The Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) underpin every workflow, providing consistent spatial registration and operator-independent organ segmentation. Plug-in modules include InvivoPLOT for 3D bioluminescence tomography, InVivoGRID for high-throughput bioluminescence imaging, and InvivoPET for PET/CT analysis. The company has issued patents on core optical tomography and image reconstruction technology (June 2023) and is developing InVivoSCAN, a modular bioluminescence imaging platform funded by NIH SBIR awards in 2025. Integrations span major preclinical imaging OEMs, including PerkinElmer IVIS Spectrum, Spectral Instruments Lago, Analytic Jena UVP iBox Scientia, Siemens, Mediso, and Sophie PET/CT systems.

Revenue is generated through SaaS subscriptions to InVivoAX plus hardware sales of BCAM molds and plug-in modules, with quote-based enterprise sales and annual billing cadence. Pricing is not publicly disclosed. The two primary customer segments are pharmaceutical and biotech companies conducting drug discovery and academic and research institutions running preclinical studies. The company has funded operations primarily through NIH SBIR grants rather than priced venture capital. With 1–10 employees distributed across the United States and active engineering hiring, Invivo Analytics remains in early-stage commercialization with patent-protected technology, advisor Christopher Contag (founder of Xenogen/IVIS), and growing product breadth.

Short descriptiontext

Invivo Analytics is a private, all-remote SaaS company that provides AI-powered preclinical imaging analysis software for pharmaceutical companies and academic researchers, combining cloud-native radiomics with proprietary hardware modules and patented automated quantification.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical imaging analysis, AI-powered radiomics, bioluminescence tomography, molecular imaging software, small animal imaging
Industry3 codes
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Laboratory Analytical Instruments3826
Product category
Preclinical Imaging Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software-as-a-Service (SaaS) Subscriptions
TypeSubscription Recurring
Description

Cloud-based SaaS platform sold as subscription using different plugin modules. Users pay for access to the InVivoAX platform for image analysis and data management.

invivo.ax
2Hardware Sales (BCAM, Plug-in Modules)
TypeHardware Sales
Description

Sale of proprietary hardware including Body Conforming Animal Molds (BCAM), InVivoPLOT mirror gantry, InVivoGRID shuttle systems, and PET/CT adapter modules.

invivo.ax
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1SaaS platform with plugin modules for different imaging modalities
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing not publicly disclosed; quote-based enterprise sales approach.

invivo.ax
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1InVivoAX
Description

Cloud-based SaaS image analysis platform for preclinical molecular imaging data analysis

invivo.ax
+4 more records
Core offering1 text field

InVivo Analytics operates InVivoAX, a cloud-native AI-powered SaaS platform for preclinical molecular imaging data analysis. The platform automates quantification of bioluminescence tomography (BLT), bioluminescence imaging (BLI), and PET/CT data using proprietary Body Conforming Animal Mold (BCAM) hardware and Organ Probability Map (OPM) software, eliminating operator bias and manual data processing while increasing throughput and reproducibility for drug discovery researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100x faster analysis compared to traditional methods
+2 more records
Product overview1 text field

Invivo Analytics offers InVivoAX, a cloud-based AI-powered SaaS platform for preclinical molecular imaging data analysis, complemented by specialized plug-in modules. The product portfolio includes InvivoPLOT (quantitative 3D bioluminescence tomography), InVivoGRID (high-throughput bioluminescence imaging), and InVivoPET (automated PET/CT analysis), all utilizing proprietary Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) technologies for consistent, operator-independent analysis. The company is developing InVivoSCAN, a modular bioluminescence imaging platform. The platform claims 100x faster analysis, 3x more data, and 5x cost savings per subject compared to CROs.

Product and service4 records
1InVivoAX
CategoryCore SaaS Platform
Description

AI-powered cloud-based SaaS platform for preclinical molecular imaging data analysis. Automates image data processing across bioluminescence tomography, bioluminescence imaging, and PET/CT modalities to accelerate drug discovery, eliminating operator bias and manual data processing while increasing data throughput and reproducibility. Accessible to unlimited users for enterprise deployments.

2InvivoPLOT (BLT Plug-in Module)
CategoryPlug-in Module
Description

Quantitative 3D bioluminescence tomography (BLT) plugin module consisting of a multi-view mirror gantry and light-transport reconstruction algorithm for automated 3D tomographic image reconstruction. Performs automated quantification using BCAM and OPM and is compatible with Spectral Instruments Imaging Lago, PerkinElmer IVIS Spectrum, and Analytic Jena UVP iBox Scientia imaging systems.

3InVivoGRID (BLI Plug-in Module)
CategoryPlug-in Module
Description

High-throughput bioluminescence imaging (BLI) plugin module with flippable animal shuttle and integrated anesthesia providing a reproducible geometric framework for small animal imaging experiments. BCAM sizes fit 14–40 gram animals. Compatible with PerkinElmer IVIS Spectrum and Spectral Instruments Imaging Lago systems.

4InVivoPET (PET/CT Plug-in Module)
CategoryPlug-in Module
Description

Cloud-based data analysis tool for PET and SPECT imaging of small animals enabling automatic biodistribution and SUV calculation, DICOM viewing, tumor volume calculation, and 3D visualization. Features BCAM shuttle adapters for Sophie, Mediso, and Siemens PET/CT systems.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers5 records
TypeBroad incumbent
Description

Revvity owns the IVIS line of in vivo optical imaging systems that InvivoPLOT and InVivoGRID integrate with, and ships its own bundled preclinical imaging software. It is the dominant incumbent in the optical preclinical imaging category where Invivo Analytics competes as a third-party analytics overlay.

TypeDirect peer
Description

Mediso manufactures small-animal PET/CT scanners (e.g., nanoScan) explicitly listed as compatible with the InvivoPET shuttle. Mediso is a direct peer in preclinical PET hardware, with bundled software competing against InvivoAX.

TypeBroad incumbent
Description

Molecular Devices provides preclinical and cell-based imaging instruments with associated analysis software for drug discovery workflows. Comparable as a bundled instrument-plus-software incumbent serving similar pharma/biotech R&D customers.

TypeDirect peer
Description

Spectral Instruments Imaging manufactures the Lago small-animal optical imaging system, which InvivoPLOT and InVivoGRID are explicitly designed to integrate with. Both companies serve the same preclinical bioluminescence/fluorescence imaging workflow.

5Bruker BioSpin (Preclinical Imaging)
TypeBroad incumbent
Description

Bruker offers preclinical MRI, PET, and optical imaging systems with bundled analysis software serving pharma and academic researchers. It represents the broad incumbent that ships instrument-and-software solutions competing against InvivoAX's third-party analytics layer.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Invivo Analytics

Preclinical Imaging Softwareinvivo.ax

Invivo Analytics is a private, all-remote SaaS company that provides AI-powered preclinical imaging analysis software for pharmaceutical companies and academic researchers, combining cloud-native radiomics with proprietary hardware modules and patented automated quantification.

What Invivo Analytics does

Invivo Analytics, Inc. is a private, all-remote SaaS company headquartered in New York that builds AI-powered preclinical imaging analysis software for pharmaceutical, biotech, and academic research buyers. Founded in 2012 by Neal Paragas (Columbia University, biology) and Alexander Klose (Freie University, physics), the company originated from work at Columbia's preclinical imaging facility and is supported by NIH, the National Cancer Institute, and Convergence Design Lab. Its core platform, InVivoAX, is a cloud-native radiomics engine that automates multi-modal image quantification, organ segmentation, and biodistribution analysis to replace manual, operator-dependent workflows in drug discovery and disease modeling. Company-published claims include 100x faster analysis, 3x more data per study, and 5x lower per-subject cost relative to traditional contract research organizations.

The product portfolio combines proprietary hardware with software modules. The Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) underpin every workflow, providing consistent spatial registration and operator-independent organ segmentation. Plug-in modules include InvivoPLOT for 3D bioluminescence tomography, InVivoGRID for high-throughput bioluminescence imaging, and InvivoPET for PET/CT analysis. The company has issued patents on core optical tomography and image reconstruction technology (June 2023) and is developing InVivoSCAN, a modular bioluminescence imaging platform funded by NIH SBIR awards in 2025. Integrations span major preclinical imaging OEMs, including PerkinElmer IVIS Spectrum, Spectral Instruments Lago, Analytic Jena UVP iBox Scientia, Siemens, Mediso, and Sophie PET/CT systems.

Revenue is generated through SaaS subscriptions to InVivoAX plus hardware sales of BCAM molds and plug-in modules, with quote-based enterprise sales and annual billing cadence. Pricing is not publicly disclosed. The two primary customer segments are pharmaceutical and biotech companies conducting drug discovery and academic and research institutions running preclinical studies. The company has funded operations primarily through NIH SBIR grants rather than priced venture capital. With 1–10 employees distributed across the United States and active engineering hiring, Invivo Analytics remains in early-stage commercialization with patent-protected technology, advisor Christopher Contag (founder of Xenogen/IVIS), and growing product breadth.

Invivo Analytics firmographics

Firmographics
Name
Invivo Analytics
Legal name
InVivo Analytics, Inc.
Website
https://invivo.ax
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Invivo Analytics is a private, all-remote SaaS company that provides AI-powered preclinical imaging analysis software for pharmaceutical companies and academic researchers, combining cloud-native radiomics with proprietary hardware modules and patented automated quantification.
Ownership category
akta.pro rank

Invivo Analytics industry classification

Industry
Product category
Preclinical Imaging Software
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
SIC
Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Preclinical imaging analysis
  • AI-powered radiomics
  • Bioluminescence tomography
  • Molecular imaging software
  • Small animal imaging

Where Invivo Analytics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Invivo Analytics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Software-as-a-Service (SaaS) Subscriptions: Cloud-based SaaS platform sold as subscription using different plugin modules. Users pay for access to the InVivoAX platform for image analysis and data management.
  2. Hardware Sales (BCAM, Plug-in Modules): Sale of proprietary hardware including Body Conforming Animal Molds (BCAM), InVivoPLOT mirror gantry, InVivoGRID shuttle systems, and PET/CT adapter modules.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSaaS platform with plugin modules for different imaging modalities

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Invivo Analytics product offering

Product offering

Core offering

InVivo Analytics operates InVivoAX, a cloud-native AI-powered SaaS platform for preclinical molecular imaging data analysis. The platform automates quantification of bioluminescence tomography (BLT), bioluminescence imaging (BLI), and PET/CT data using proprietary Body Conforming Animal Mold (BCAM) hardware and Organ Probability Map (OPM) software, eliminating operator bias and manual data processing while increasing throughput and reproducibility for drug discovery researchers.

Product overview

Invivo Analytics offers InVivoAX, a cloud-based AI-powered SaaS platform for preclinical molecular imaging data analysis, complemented by specialized plug-in modules. The product portfolio includes InvivoPLOT (quantitative 3D bioluminescence tomography), InVivoGRID (high-throughput bioluminescence imaging), and InVivoPET (automated PET/CT analysis), all utilizing proprietary Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) technologies for consistent, operator-independent analysis. The company is developing InVivoSCAN, a modular bioluminescence imaging platform. The platform claims 100x faster analysis, 3x more data, and 5x cost savings per subject compared to CROs.

Differentiator

Problem solved

Functional benefit

Brands

  • InVivoAX: Cloud-based SaaS image analysis platform for preclinical molecular imaging data analysis
  • InvivoPLOT
  • InVivoGRID
  • InVivoPET
  • InVivoSCAN

Products and services

  • InVivoAX AI-powered cloud-based SaaS platform for preclinical molecular imaging data analysis. Automates image data processing across bioluminescence tomography, bioluminescence imaging, and PET/CT modalities to accelerate drug discovery, eliminating operator bias and manual data processing while increasing data throughput and reproducibility. Accessible to unlimited users for enterprise deployments.
  • InvivoPLOT (BLT Plug-in Module) Quantitative 3D bioluminescence tomography (BLT) plugin module consisting of a multi-view mirror gantry and light-transport reconstruction algorithm for automated 3D tomographic image reconstruction. Performs automated quantification using BCAM and OPM and is compatible with Spectral Instruments Imaging Lago, PerkinElmer IVIS Spectrum, and Analytic Jena UVP iBox Scientia imaging systems.
  • InVivoGRID (BLI Plug-in Module) High-throughput bioluminescence imaging (BLI) plugin module with flippable animal shuttle and integrated anesthesia providing a reproducible geometric framework for small animal imaging experiments. BCAM sizes fit 14–40 gram animals. Compatible with PerkinElmer IVIS Spectrum and Spectral Instruments Imaging Lago systems.
  • InVivoPET (PET/CT Plug-in Module) Cloud-based data analysis tool for PET and SPECT imaging of small animals enabling automatic biodistribution and SUV calculation, DICOM viewing, tumor volume calculation, and 3D visualization. Features BCAM shuttle adapters for Sophie, Mediso, and Siemens PET/CT systems.

Quantifiable outcome

  • 100x faster analysis compared to traditional methods
  • +2 more outcomes

Companies that use Invivo Analytics

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Invivo Analytics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature7 records

Invivo Analytics partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Invivo Analytics competitors and assessment

Company assessment

Broad incumbents

  • Revvity (formerly PerkinElmer Life Sciences): Revvity owns the IVIS line of in vivo optical imaging systems that InvivoPLOT and InVivoGRID integrate with, and ships its own bundled preclinical imaging software. It is the dominant incumbent in the optical preclinical imaging category where Invivo Analytics competes as a third-party analytics overlay.
  • Molecular Devices (Danaher): Molecular Devices provides preclinical and cell-based imaging instruments with associated analysis software for drug discovery workflows. Comparable as a bundled instrument-plus-software incumbent serving similar pharma/biotech R&D customers.
  • Bruker BioSpin (Preclinical Imaging): Bruker offers preclinical MRI, PET, and optical imaging systems with bundled analysis software serving pharma and academic researchers. It represents the broad incumbent that ships instrument-and-software solutions competing against InvivoAX's third-party analytics layer.

Direct peers

  • Mediso Medical Imaging Systems: Mediso manufactures small-animal PET/CT scanners (e.g., nanoScan) explicitly listed as compatible with the InvivoPET shuttle. Mediso is a direct peer in preclinical PET hardware, with bundled software competing against InvivoAX.
  • Spectral Instruments Imaging: Spectral Instruments Imaging manufactures the Lago small-animal optical imaging system, which InvivoPLOT and InVivoGRID are explicitly designed to integrate with. Both companies serve the same preclinical bioluminescence/fluorescence imaging workflow.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Invivo Analytics social profiles

Digital presence

Invivo Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Invivo Analytics leadership team

Management profile

Number of profiles

Profiles5 records

Invivo Analytics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Invivo Analytics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invivo Analytics

What does Invivo Analytics do?

InVivo Analytics operates InVivoAX, a cloud-native AI-powered SaaS platform for preclinical molecular imaging data analysis. The platform automates quantification of bioluminescence tomography (BLT), bioluminescence imaging (BLI), and PET/CT data using proprietary Body Conforming Animal Mold (BCAM) hardware and Organ Probability Map (OPM) software, eliminating operator bias and manual data processing while increasing throughput and reproducibility for drug discovery researchers.

Is Invivo Analytics a public or private company?

Invivo Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Invivo Analytics founded?

Invivo Analytics was founded in 2012. It employs 1 to 10 people.

Where is Invivo Analytics based?

Invivo Analytics is headquartered in New York, United States, in the North America region.

How does Invivo Analytics make money?

Two revenue lines are on record. Software-as-a-Service (SaaS) Subscriptions are the primary driver. The others are hardware Sales (BCAM, Plug-in Modules).

Who are Invivo Analytics's main competitors?

Broad incumbents on record are Revvity (formerly PerkinElmer Life Sciences), Molecular Devices (Danaher) and Bruker BioSpin (Preclinical Imaging). Direct peers are Mediso Medical Imaging Systems and Spectral Instruments Imaging.

Does Invivo Analytics have an API?

No public API is recorded for Invivo Analytics.

What industry is Invivo Analytics in?

Invivo Analytics's product category is Preclinical Imaging Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals